Health and Healthcare

iShares Biotechnology ETF : IBB

All IBB Articles

63 Articles

Jon C. Ogg | Feb 25, 2016 at 5:15 PM EST

Why Citi Sees Huge Upside in 4 Top Biotechs Now

Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four…

Trey Thoelcke | Dec 18, 2015 at 7:10 AM EST

4 Top Biotech Stocks for 2016

Biotech looks set to close out 2015 as its worst performing year since 2008. But can we expect a better…

Trey Thoelcke | Oct 22, 2015 at 8:25 AM EDT

The Strongest Performing Biotech in 2015 Is a Surprise

ThinkstockBiotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the…

Jon C. Ogg | Sep 30, 2015 at 2:40 PM EDT

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

A report on Wednesday from Janney Capital Markets has targeted several iotech bcompanies it believes are now grossly oversold.

Jon C. Ogg | Sep 21, 2015 at 1:20 PM EDT

The Political Tweet That Thrashed the Biotech Sector

On Monday, a simple tweet from presidential candidate Hillary Clinton managed to wreck the biotech sector.

Trey Thoelcke | Jun 25, 2015 at 10:05 AM EDT

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

If you missed the biotech run and want to try to catch the train this late in the game, it…

Paul Ausick | Apr 21, 2015 at 11:35 AM EDT

Will Amgen Earnings Shape Biotech for the Rest of 2015?

After markets close on Tuesday, Amgen, the second-largest biotech, is scheduled to announce its first-quarter results.

Jon C. Ogg | Mar 23, 2015 at 10:35 AM EDT

The Top 5 Biotech Stocks of 2015 — Average Gains So Far Over 200%

ThinkstockThe multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks…

Jon C. Ogg | Jul 20, 2014 at 9:11 AM EDT

Top Biotech Earnings Previews for the Week Ahead

ThinkstockEarnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector…

Jon C. Ogg | Jul 15, 2014 at 11:05 AM EDT

Yellen Sees Social Media, Biotech, Junk Bonds and Leveraged Loans Overvalued

ThinkstockFed Chair Janet Yellen offered a bit of a surprise in her semiannual Monetary Policy Report in front of Congress…

cgblaine22 | Apr 26, 2014 at 8:30 AM EDT

Biotech: The Poster Child for Market Volatility in 2014

The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5.…

Jon C. Ogg | Apr 15, 2014 at 2:10 PM EDT

Eight Serious Market Indicators to Watch During This Correction

Photo by Spencer Platt/Getty ImagesAny time a market peaks, investors and commentators talk about the expectations of a sell-off. The…

Jon C. Ogg | Apr 2, 2014 at 8:20 AM EDT

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…

Trey Thoelcke | Mar 24, 2014 at 9:55 AM EDT

Top Biotechnology Stocks On Sale Again

For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

1 2 3 4 5

iShares Biotechnology ETF : IBB

All IBB Articles

Why Citi Sees Huge Upside in 4 Top Biotechs Now

4 Top Biotech Stocks for 2016

The Strongest Performing Biotech in 2015 Is a Surprise

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

The Political Tweet That Thrashed the Biotech Sector

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

Will Amgen Earnings Shape Biotech for the Rest of 2015?

The Top 5 Biotech Stocks of 2015 — Average Gains So Far Over 200%

Top Biotech Earnings Previews for the Week Ahead

Yellen Sees Social Media, Biotech, Junk Bonds and Leveraged Loans Overvalued

Biotech: The Poster Child for Market Volatility in 2014

Eight Serious Market Indicators to Watch During This Correction

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Top Biotechnology Stocks On Sale Again

Market Take: Biotech Suffers Under Government Shutdown Too!

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

iShares Biotechnology ETF : IBB

All IBB Articles

Why Citi Sees Huge Upside in 4 Top Biotechs Now

4 Top Biotech Stocks for 2016

The Strongest Performing Biotech in 2015 Is a Surprise

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

The Political Tweet That Thrashed the Biotech Sector

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

Will Amgen Earnings Shape Biotech for the Rest of 2015?

The Top 5 Biotech Stocks of 2015 — Average Gains So Far Over 200%

Top Biotech Earnings Previews for the Week Ahead

Yellen Sees Social Media, Biotech, Junk Bonds and Leveraged Loans Overvalued

Biotech: The Poster Child for Market Volatility in 2014

Eight Serious Market Indicators to Watch During This Correction

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Top Biotechnology Stocks On Sale Again

Market Take: Biotech Suffers Under Government Shutdown Too!

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not